Entrée Capital
Venture Capital. Pre-Seed – Series B.
- Stages
- Pre-Seed, Seed, Series A, Series B
- Focus
- AI, Deep Tech, Crypto, B2B Software, Fintech, Security & Defense, Health & Bio
- Invests in
- Israel, Europe, US
- Offices
- Tel Aviv, Israel; London, United Kingdom; New York, United States
- Latest fund
- €110M
- Website
- entreecap.com
- Elsewhere
- LinkedIn · X
About
Entrée Capital is a multi-fund venture firm led by Avi Eyal, its co-founder and Managing Partner, with General Partners Ran Achituv, Eran Bielski and Yoni Osherov and Partner Saul Levin. It also has offices in Tel Aviv and New York. A separate life-sciences arm, Entrée Bio, is run by Yael Gruenbaum-Cohen and Michelle Lynn Hall. Entrée co-founded SigmaLabs, a non-profit accelerator for young first-time founders. Portfolio companies get help from in-house staff: an organizational development partner, a VP of Data who mentors portfolio data teams, and a marketing lead who works with founders on positioning. The firm has said it can decide quickly, at times within 24 hours, and that it holds back roughly half of a fund for follow-on rounds in its strongest companies. It also publishes research reports, such as a 2026 study on enterprise quantum readiness.
Notable investments
Last checked 13 November 2026. Something wrong or out of date? Write to hi@schub.tech.
Previous: Endeit CapitalNext: Episode 1 Ventures
Building a company in Europe? Schub invests €25k for 2% and gives you a weekly 1:1 with a founder coach.
Apply to Schub